Citations

Showing 10 of 108162 citations.

BRAF p.V600E associated poly-neoplastic syndrome
Moustafa, Muhamad Alhaj , Jiang, Liuyan , Jones, Jeremy , Lou, Yanyan , Sokumbi, Olayemi , Moustafa, Muhamad Alhaj , Kuhlman, Justin J. , Tun, Han W. , Sokumbi, Olayemi , Jones, Jeremy C

Mayo Clinic

Rare Tumors | April 28, 2021 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/20363613211012929 | PMID 33995981 Get It

We report a male patient who developed eight different cancers between ages 57 and 64. BRAF p.V600E mutation was detected in Langerhans cell histiocytosis, chronic lymphocytic leukemia, histiocytic sarcoma, melanoma, and adenocarcinoma of the lung. It was not detected in multiple myeloma, basal cell carcinoma, and papillary thyroid cancer. BRAF p.V600E was not detected in normal skin tissue biopsy indicating that BRAF V600E was a somatic mutation affecting cancer cells. The presence of eight different cancers with five of them positive for BRAF p.V600E in a single patient is unprecedented. This type of BRAF p.V600E-associated poly-neoplastic syndrome has never been reported in the medical literature.
O43: CLINICAL IMPACT OF GENE FUSIONS IN BREAST CANCER BRAIN METASTASES
Cosgrove, Nicola , Furney, SJ, Oesterreich, Steffi , Lee, AV, Couch, FJ, Cosgrove, Nicola , Varešlija, Damir , Young, Leonie

Mayo Clinic

British Journal of Surgery | April 27, 2021 | Volume: 108 | Issue: Supplement_1 | Pages: No page available

10.1093/bjs/znab117.043 Get It

Abstract Introduction The incidence of brain metastases is increasing despite longer survival rates for patients with advanced breast cancer. The identification of novel therapeutic targets for these patients is an urgent unmet clinical need. Sequencing of metastatic tumours have largely focused on mutations however gene fusions have an important, yet underappreciated role in tumorigenesis and disease progression. In this study, we investigate the role of gene fusions in brain metastatic disease and their impact on altered therapeutic responses. Method RNA sequencing was performed on the largest reported cohort of patient matched primary and resected brain metastatic tumours (45 patients n=90 samples). Expressed gene fusions were detected computationally using STAR-Fusion and Arriba. Result We identified differential gene fusion burden in brain metastatic tumours (medium of 58) vs. primary breast tumours (medium of 38) (p < 0.05). Enrichment for fusions in pathways associated with tumour cell plasticity and proliferation with recurrent fusions in known cancer driver genes related to MAPK, HER signaling identified. Of note, a fusion in CDK12 is of clinical importance. Increased genomic alterations and over expression of CDK12 is associated with brain metastases free survival in an independent cohort of primary breast tumours with a recorded history of brain metastases. It has been proposed that inhibition of CDK12 may induce BRCAness in tumours making them sensitive to PARP inhibition. Conclusion These results highlight the significant role of gene fusions in breast cancer brain metastases. Abbreviations MAPK Mitogen Activated Protein Kinase, HER Human Epidermal Receptor, CDK12 Cyclin Dependent Kinase 12 Take-home message We highlight the significant role of gene fusions in breast cancer brain metastases and offer specific actionable genomic alterations to be exploited.
Coccidioidomycosis in Allogeneic Stem Cell Transplant Recipients: Case Series and Review of the Literature
Saling, Christopher , Gea‐Banacloche, Juan , Trickett, John S. , Blair, Janis E. , Saling, Christopher F.

Mayo Clinic

Journal of Fungi | April 27, 2021 | Volume: 7 | Issue: 5 | Pages: 339

10.3390/jof7050339 | PMID 33925759 Get It

Coccidioides is an endemic fungus of the Southwest United States that causes the disease coccidioidomycosis. Immunocompromised persons are at increased risk for severe infection and dissemination. One such population is allogeneic bone marrow transplant (allo-HCT) recipients, but accounts of coccidioidal infection in these patients have rarely been documented. We present two cases of Coccidioides in allo-HCT recipients with good outcomes: one patient who developed pulmonary coccidioidomycosis in the late post-engraftment phase and another with known controlled disseminated infection at the time of transplant. A review of the literature identified 19 allo-HCT recipients with coccidioidomycosis. Due to the limited published literature, no guidelines have yet been established regarding optimal prophylaxis and treatment of Coccidioides infection in allo-HCT recipients. Candidates for transplantation should undergo a rigorous pre-transplant assessment to identify evidence of prior or active coccidioidomycosis. In our experience, patients who visit or live in Coccidioides-endemic areas should receive primary prophylaxis for at least the first 100 days post-transplant, and duration should be extended as long as the patient remains on immunosuppression. Those with prior infection should receive secondary prophylaxis while immunosuppressed. Patients with active infection should have treatment and stabilization of infection and continue anti-fungal treatment through immunosuppression.
Promoting Neuronal Outgrowth Using Ridged Scaffolds Coated with Extracellular Matrix Proteins
Siddiqui, Ahad M. , Brunner, Rosa, Harris, Greg M. , Miller, A. Lee , Waletzki, Brian E., Schmeichel, Ann M., Schwarzbauer, Jean E. , Yaszemski, Michael J. , Windebank, Anthony J. , Madigan, Nicolas N. , Harris, Gregory M , Miller, Alan Lee , Madigan, Nicolas N , Schwartz, Jeffrey

Mayo Clinic

Biomedicines | April 27, 2021 | Volume: 9 | Issue: 5 | Pages: 479

10.3390/biomedicines9050479 | PMID 33925613 Get It

Spinal cord injury (SCI) results in cell death, demyelination, and axonal loss. The spinal cord has a limited ability to regenerate, and current clinical therapies for SCI are not effective in helping promote neurologic recovery. We have developed a novel scaffold biomaterial that is fabricated from the biodegradable hydrogel oligo(poly(ethylene glycol)fumarate) (OPF). We have previously shown that positively charged OPF scaffolds (OPF+) in an open spaced, multichannel design can be loaded with Schwann cells to support axonal generation and functional recovery following SCI. We have now developed a hybrid OPF+ biomaterial that increases the surface area available for cell attachment and that contains an aligned microarchitecture and extracellular matrix (ECM) proteins to better support axonal regeneration. OPF+ was fabricated as 0.08 mm thick sheets containing 100 μm high polymer ridges that self-assemble into a spiral shape when hydrated. Laminin, fibronectin, or collagen I coating promoted neuron attachment and axonal outgrowth on the scaffold surface. In addition, the ridges aligned axons in a longitudinal bipolar orientation. Decreasing the space between the ridges increased the number of cells and neurites aligned in the direction of the ridge. Schwann cells seeded on laminin coated OPF+ sheets aligned along the ridges over a 6-day period and could myelinate dorsal root ganglion neurons over 4 weeks. This novel scaffold design, with closer spaced ridges and Schwann cells, is a novel biomaterial construct to promote regeneration after SCI.
Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy
Moaven, Omeed , Mangieri, Christopher W. , Anastasiadis, Panos Z. , Borad, Mitesh J. , A Stauffer, John , Borad, Mitesh J , W Mangieri, Christopher , Moaven, Omeed , Stauffer, John

Mayo Clinic

JCO Precision Oncology | April 27, 2021 | Volume: No volume available | Issue: 5 | Pages: 733-743

10.1200/po.21.00003 | PMID 34250395 Get It

Despite advancements in cancer therapy that have occurred over the past several decades, successful treatment of advanced malignancies remains elusive. Substantial resources and significant efforts have been directed toward the development of novel therapeutic modalities to improve patient outcomes. Oncolytic viruses (OVs) are emerging tools with unique characteristics that have attracted great interest in developing effective anticancer treatment. The original attraction was directed toward selective replication and cell-specific toxicity, two unique features that are either inherent to the virus or could be conferred by genetic engineering. However, recent advancements in the knowledge and understanding of OVs are shifting the therapeutic paradigm toward a greater focus on their immunomodulatory role. Nonetheless, there are still significant obstacles that remain to be overcome to enhance the efficiency of OVs as effective therapeutic modalities and potentially establish them as part of standard treatment regimens. In this review, we discuss advances in the design of OVs, strategies to enhance their therapeutic efficacy, functional translation into the clinical settings, and various obstacles that are still encountered in the efforts to establish them as effective anticancer treatments.
Underlying pathology identified after 20 years of disease course in two cases of slowly progressive frontotemporal dementia syndromes
Hokelekli, Fatma Ozlem , Whitwell, Jennifer L. , Uitti, Ryan J. , Pham, Nha Trang Thu, Lowe, Val J. , Josephs, Keith A. , Machulda, Mary M. , Jones, David T. , Giannini, Caterina , Baker, Matthew , Dickson, Dennis W.

Mayo Clinic

Neurocase | April 27, 2021 | Volume: 27 | Issue: 2 | Pages: 212-222

10.1080/13554794.2021.1918723 | PMID 33904372 Get It

Feasibility of a Health Coaching and Home-Based Rehabilitation Intervention With Remote Monitoring for COPD
Benzo, Roberto P. , Ridgeway, Jennifer L. , Hoult, Johanna, Novotny, Paul J. , Thomas, B.E., Lam, Nyanjok M, Benzo, M.V. , Kramer, K. , Seifert, Sara J. , Ridgeway, Jennifer, Hoult, Johanna P, Novotny, Paul, Thomas, Benjamin E, V Benzo, Maria, Ridgeway, Jennifer L

Mayo Clinic

Respiratory Care | April 27, 2021 | Volume: 66 | Issue: 6 | Pages: 960-971

10.4187/respcare.08580 | PMID 33906954 Get It

BACKGROUND: Pulmonary rehabilitation is an effective treatment for patients with COPD, but patient uptake and adherence to the current offering of center-based pulmonary rehabilitation is modest due to transportation, access, poverty, and frailty, and even more so in the context of the COVID pandemic. Home-based options have been proposed and were found noninferior to center-based rehabilitation; however, there is a lack of home-based programs, and more understanding is needed. We aimed to test the feasibility, uptake, and adherence to a home-based program for COPD rehabilitation with health coaching. METHODS: We conducted a randomized trial with a wait-list controlled design to evaluate the effects of a home-based program with health coaching on breathlessness in subjects with moderate to severe COPD unable to attend the regular pulmonary rehabilitation program. The 8-week intervention consisted of video-guided exercises to be done 6 times a week and captured with a computer tablet. Health coaching was done weekly over the telephone to review subject activity and symptoms and to provide an opportunity for the subject to define their weekly goals. The primary outcomes were uptake, adherence, and Chronic Respiratory Questionnaire (CRQ) Dyspnea Domain. Secondary outcomes were self-management abilities and CRQ Emotions-Mastery-Fatigue. RESULTS: 154 subjects with moderate to severe COPD were randomized. Subject adherence was 86% to the proposed 6-times a week exercise routine. There ( P = .062) was no significant difference in breathlessness (CRQ dyspnea). There was a significant improvement in self-management abilities ( P < .001). The results of the qualitative interviews showed high levels of acceptability of the program. CONCLUSIONS: The tested home-based rehabilitation program with health coaching was feasible, highly acceptable, showed a high degree of adherence, and improved self-management abilities. This study offers seminal information for home-based rehabilitation programs to design alternative options of rehabilitation to individuals with COPD that cannot attend to the well-established center-based pulmonary rehabilitation. (ClinicalTrials.gov registration NCT02557178.)
The Stress of Lung Aging: Endoplasmic Reticulum and Senescence Tête-à-Tête
Ngassie, Maunick Lefin Koloko , Brandsma, Corry‐Anke , Prakash, Y. S. , Burgess, Janette K. , Prakash, Y S , Burgess, Janette K , Koloko Ngassie, Maunick Lefin , Brandsma, Corry-Anke , Gosens, Reinoud

Mayo Clinic

Physiology | April 27, 2021 | Volume: 36 | Issue: 3 | Pages: 150-159

10.1152/physiol.00039.2020 | PMID 33904785 Get It

Beyond the structural changes, features including the dysregulation of endoplasmic reticulum (ER) stress response and increased senescence characterize the lung aging. ER stress response and senescence have been reported to be induced by factors like cigarette smoke. Therefore, deciphering the mechanisms underlying ER and senescent pathways interaction has become a challenge. In this review we highlight the known and unknown regarding ER stress response and senescence and their cross talk in aged lung.